127120 — DNA Link Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩54bn
- KR₩52bn
- KR₩22bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,697 | 36,945 | 5,869 | 10,784 | 6,568 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,957 | 3,930 | 24,364 | 3,395 | 3,788 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,644 | 47,394 | 33,375 | 18,698 | 14,486 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,902 | 3,201 | 5,782 | 7,033 | 8,171 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 25,900 | 52,544 | 41,017 | 43,507 | 38,758 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,488 | 14,573 | 9,332 | 10,502 | 8,924 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,237 | 13,839 | 8,245 | 15,617 | 12,480 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,663 | 38,705 | 32,772 | 27,890 | 26,278 |
Total Liabilities & Shareholders' Equity | 25,900 | 52,544 | 41,017 | 43,507 | 38,758 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |